4)使用者在接收、处理、保存、丢弃、转让及使用细胞的时候要遵守国内外有关的法律法规,充分考虑可能存在的风险和责任,采取适当的安全和处理措施尽量降低对健康或环境的危害。
左氧氟沙星相关物质B 90-15-3 Levofloxacin Related CoMpound B;(S)-9,10,difluro-3-Methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
左乙拉西坦 154-17-6 LevetiracetaM
左乙拉西坦外消旋混合物 118-10-5 LevetiracetaM RaceMic Mixture
左乙拉西坦相关物质A 69-89-6 LevetiracetaM Related CoMpound A;(S)-N-(1-aMino-1-oxobutan-2-yl)-4-chlorobutanaMide
左乙拉西坦相关物质B 569-64-2 LevetiracetaM Related CoMpound B;(S)-2-aMinobutanaMide hydrochloride
唑泊司他 1330-20-7 Zopolrestat
唑泊司他 1330-20-7 Zopolrestat
左乙拉西坦相关物质B 569-64-2 LevetiracetaM Related CoMpound B;(S)-2-aMinobutanaMide hydrochloride
左乙拉西坦相关物质A 69-89-6 LevetiracetaM Related CoMpound A;(S)-N-(1-aMino-1-oxobutan-2-yl)-4-chlorobutanaMide
左乙拉西坦外消旋混合物 118-10-5 LevetiracetaM RaceMic Mixture
左乙拉西坦 154-17-6 LevetiracetaM
左氧氟沙星相关物质B 90-15-3 Levofloxacin Related CoMpound B;(S)-9,10,difluro-3-Methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
左氧氟沙星相关物质A 85-85-8 Levofloxacin Related CoMpound A;(S)-9-fluro-3-Methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
左氧氟沙星 144-62-7 Levofloxacin
左旋糖酸钙,二水 12027-06-4 LEVULINIC ACID CALCIUM SALT DIHYDRATE
左旋-beta-蒎烯(2-8℃) 98-89-5 (1S)-(1)-beta-Pinene
左炔诺孕酮 6066-82-6 Levonorgestrel
左卡尼汀相关物质A 70700-30-0 Levocarnitine Related CoMpound A;3-carboxy-N,N,N-triMethyl-2-propen-1-aMiniuM chloride
组胺磷酸盐;二磷酸组织胺 484-11-7 HistaMine phosphate;Histapon
足球烯 596-01-0 FULLERENE
人肝内胆管癌细胞株;IHC-ST1棕榈酸乙酯;软脂酸乙酯;十六酸乙酯 10114-58-6 Ethyl palMitate;Ethyl hexadecanoate;Ethyl hexadecylate;Ethyl cetylate;